Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sleep and metabolic control: waking to a problem?

Michael I Trenell1, Nathaniel S Marshall, Naomi L Rogers

  • 1Sleep and Circadian Research Group, Woolcock Institute of Medical Research, Sydney, NSW, Australia.

Clinical and Experimental Pharmacology & Physiology
|January 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CPAP to Reduce the Risk of Cancer in OSA?-A Meta-Analysis of 3 RCTs.

Journal of sleep research·2026
Same author

Digital Cognitive Behavioural Therapy for Insomnia Compared to Sleep Health Education in Older Adults With Mild Cognitive Impairment and Insomnia: A Feasibility Randomised Controlled Trial.

Journal of sleep research·2026
Same author

Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Placebo-Controlled Crossover Trial.

Journal of sleep research·2026
Same author

The impact of exercise on fat free mass reduction during very low energy diet-induced weight loss in adults with overweight or obesity: A systematic review and meta-analysis.

Obesity research & clinical practice·2025
Same author

Pharmacotherapy for obstructive sleep apnea: a critical review of randomized placebo-controlled trials.

Sleep medicine reviews·2025
Same author

Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial.

Journal of sleep research·2025

Insufficient sleep impacts metabolic health, increasing risks for cardiovascular disease and Type 2 diabetes. Factors like sex, age, and obesity further complicate this relationship, highlighting sleep as a modifiable health risk.

Area of Science:

  • Metabolic health
  • Endocrinology
  • Sleep science

Background:

  • Sleep duration is linked to endocrine changes, including insulin action.
  • A U-shaped relationship exists between sleep duration and risks for mortality, cardiovascular disease, and Type 2 diabetes.
  • Chronic sleep restriction is increasingly prevalent, negatively affecting glucose control and appetite.

Purpose of the Study:

  • To review the association between sleep and metabolism.
  • To examine sleep duration's role in disease development.
  • To explore how sex differences, aging, and obesity influence sleep-metabolism links.

Main Methods:

  • Literature review of studies on sleep, metabolism, and disease.
  • Analysis of endocrine changes related to sleep.

Related Experiment Videos

  • Examination of epidemiological data on sleep duration and health outcomes.

    • Main Results:

    • Sleep duration influences insulin action and glucose control.
    • Sleep restriction impairs metabolic function and increases appetite.
    • Sex hormones, aging, and obesity are identified as key modulators of the sleep-metabolism relationship.

    Conclusions:

    • Sleep is crucial for metabolic control.
    • Insufficient sleep is a potential modifiable risk factor for Type 2 diabetes.
    • Further research is needed to understand the interplay of sex, aging, and obesity in sleep-related metabolic dysfunction.